This article in Corporate Disputes highlights a recent roundtable discussion featuring Group Vice President and Life Sciences Practice Leader Greg Bell and his thoughts on trends in intellectual property and the impact of high-profile IP infringement cases on the life sciences landscape more broadly.
Assessing the novel antitrust claims in the Humira case
In this Law360 article, the authors consider perspectives relevant to antitrust claims based on the use of “patent thickets.” A timely example is provided by...